Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Search by expertise, name or affiliation
Telomerase activity in normal leukocytes and in hematologic malignancies
Christopher M. Counter
, Jyothi Gupta
, Calvin B. Harley
, Brian Leber
, Silvia Bacchetti
Research output
:
Contribution to journal
›
Article
›
peer-review
644
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Telomerase activity in normal leukocytes and in hematologic malignancies'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Leukocytes
100%
Telomerase
100%
Hematological Malignancies
100%
Telomere
100%
Telomerase Activity
100%
Bone Marrow
50%
Chronic Lymphocytic Leukemia
50%
Myelodysplastic Syndrome
50%
Cell Proliferation
25%
Transformed Cells
25%
Cell Division
25%
Leukemia Patients
25%
Acute Myeloid Leukemia
25%
Cord Blood
25%
Selective Pressure
25%
Early Disease
25%
Temporal Patterns
25%
Cell Senescence
25%
Somatic Tissues
25%
Telomeric DNA
25%
Eukaryotic Chromosome
25%
Immortality
25%
Ovarian Carcinoma Cells
25%
Efficient Mechanism
25%
Telomerase Expression
25%
Telomere Loss
25%
Patient Activity
25%
Process Thought
25%
Telomere Maintenance
25%
Medicine and Dentistry
Leukocyte
100%
Hematologic Malignancy
100%
Telomerase
100%
Telomere
55%
Diseases
33%
B-Cell Chronic Lymphocytic Leukemia
22%
Myelodysplastic Syndrome
22%
In Vitro
11%
Cancer
11%
Cell Proliferation
11%
Transformed Cell
11%
Cell Division
11%
Krukenberg Tumor
11%
Cord Blood
11%
Somatics
11%
Acute Myeloid Leukemia
11%
Carcinoma Cell
11%
Cellular Senescence
11%
Telomere Homeostasis
11%
Immunology and Microbiology
Leukocyte
100%
Telomere
100%
Cell Proliferation
20%
Myeloid
20%
Transformed Cell
20%
Cell Division
20%
Carcinoma Cell
20%
Telomere Homeostasis
20%
In Vitro
20%
Pharmacology, Toxicology and Pharmaceutical Science
Hematologic Malignancy
100%
Telomerase
100%
Diseases
33%
Chronic Lymphatic Leukemia
22%
Myelodysplastic Syndrome
22%
Ovary Carcinoma
11%
Acute Myeloid Leukemia
11%